ICU Medical
ICUI
247 hedge funds and large institutions have $3.5B invested in ICU Medical in 2022 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 77 increasing their positions, 92 reducing their positions, and 25 closing their positions.
43% more call options, than puts
Call options by funds: $22M | Put options by funds: $15.4M
40% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 25
2% more funds holding
Funds holding: 243 → 247 (+4)
7% less capital invested
Capital invested by funds: $3.78B → $3.5B (-$279M)
12.2% less ownership
Funds ownership: 105.18% → 92.98% (-12%)
16% less repeat investments, than reductions
Existing positions increased: 77 | Existing positions reduced: 92
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$72.4M |
| 2 |
Schroder Investment Management Group
London,
United Kingdom
|
+$13.9M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$11.6M |
| 4 |
Neuberger Berman Group
New York
|
+$9.61M |
| 5 |
BlackRock
New York
|
+$8.61M |
Top Sellers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$374M |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$24.1M |
| 3 |
KHCM
Kettle Hill Capital Management
New York
|
-$15.4M |
| 4 |
NI
Nuance Investments
Kansas City,
Missouri
|
-$13.4M |
| 5 |
NC
Nitorum Capital
New York
|
-$12.5M |
ICUI Hedge Fund Activity: Q4 2022 in Review
247 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in ICU Medical (ICUI) for Q4 2022, worth a combined $3.5B — down 7.4% from $3.78B a quarter earlier.
Buyers outnumbered sellers: 35 funds opened new ICUI positions and 25 closed out — a net gain of 10 holders — while 77 added to existing stakes and 92 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $72.4M. The largest seller was Janus Henderson Group, cutting an estimated $374M.
- 247 institutional investors held ICU Medical (ICUI) as of Q4 2022, up from 243 in Q3 2022.
- Funds reported $3.5B of ICU Medical stock for Q4 2022, down 7.4% quarter-over-quarter.
- 35 funds opened new ICU Medical positions in Q4 2022 and 25 closed out, a net change of +10 holders.
- The largest ICU Medical buyer in Q4 2022 was Morgan Stanley, an estimated $72.4M added.
- The largest ICU Medical seller in Q4 2022 was Janus Henderson Group, an estimated $374M sold.
Based on aggregated 13F filings for Q4 2022.